학술논문
FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes
Document Type
Article
Author
de Poel, E.; Spelier, S.; Hagemeijer, M.C.; van Mourik, P.; Suen, S.W.F.; Vonk, A.M.; Brunsveld, J.E.; Ithakisiou, G.N.; Kruisselbrink, E.; Oppelaar, H.; Berkers, G.; de Winter de Groot, K.M.; Heida-Michel, S.; Jans, S.R.; van Panhuis, H.; Bakker, M.; van der Meer, R.; Roukema, J.; Dompeling, E.; Weersink, E.J.M.; Koppelman, G.H.; Blaazer, A.R.; Muijlwijk-Koezen, J.E.; van der Ent, C.K.; Beekman, J.M.
Source
In Journal of Cystic Fibrosis May 2023 22(3):548-559
Subject
Language
ISSN
1569-1993